Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors.

Cancer chemotherapy and pharmacology(2023)

引用 0|浏览8
暂无评分
摘要
GOV: NCT03333824.
更多
查看译文
关键词
Adavosertib, AZD1775, Pharmacokinetics, CYP3A
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要